| 000 | 02806cam a22003977a 4500 | ||
|---|---|---|---|
| 001 | 19108 | ||
| 003 | CUTN | ||
| 005 | 20150619152921.0 | ||
| 008 | 111208s2012 enka b 001 0 eng | ||
| 010 | _a 2011293621 | ||
| 016 | 7 |
_a101572294 _2DNLM |
|
| 020 | _a9780123849991 | ||
| 020 | _a0123849993 | ||
| 035 | _a(OCoLC)ocn711573687 | ||
| 040 |
_aNLM _beng _cNLM _dSFB _dYDXCP _dWSU _dCDX _dFRH _dDLC |
||
| 042 |
_anlmcopyc _alccopycat |
||
| 050 | 0 | 0 |
_aRC270.8 _b.D53 2012 |
| 060 | 0 | 0 | _a2011 K-597 |
| 060 | 1 | 0 | _aQZ 267 |
| 082 | 0 | 0 |
_a616.99/4042 _223 |
| 245 | 0 | 0 |
_aDNA repair in cancer therapy : _bmolecular targets and clinical applications / _cedited by Mark R. Kelley. |
| 250 | _a1st ed. | ||
| 260 |
_aLondon ; _aWaltham, MA : _bElsevier/Academic Press, _c2012. |
||
| 300 |
_axiii, 316 p. : _bill. ; _c29 cm. |
||
| 504 | _aIncludes bibliographical references and index. | ||
| 505 | 0 | _aIntroduction and overview of current targets: bench to clinic / Mark R. Kelley -- 2. MGMT a critical DNA repair gene target for chemotherapy resistance / Stanton L. Gerson and Lili Liu -- 3. Blockade of base excision repair: inhibition of small lesions results in big consequences to cancer cells / Melissa Fishel and Carlo Vascotto -- 4. PARP inhibitors -- scientific rationale and clinical development for cancer / Ruth Plummer, Nicola J. Curtin and Yvette Drew -- 5. Chemotherapy intervention by inhibiting DNA polymerases for therapeutic intervention / Anthony J. Berdis -- 6. Targeting the nucleotide excision repair pathway for therapeutic applications / John Turchi and Stephan M. Patrick -- 7. Homologous recombination and ATM/ATR targets / Henning Willers, Lee Zou and Heike N. Pfaffle -- 8. DNA double strand break repair by nonhomologous end joining and its clinical relevance / Michael Weinfeld and Susan Lees-Miller -- 9. Defective MMR-c-Abl-p73-GADD45alpha expression in cancer chemoresistance / David Boothman and Long Shan Li -- 10. DNA repair signaling targets / Susan Ashwell -- 11. Redox regulation of DNA repair and therapeutic / Millie M. Georgiadis -- 12. Personalized cancer medicine: DNA repair alterations is a promising predictive marker in cancer / Srinivasan Madhusudan -- 13. The role of DNA damage and repair in neurotoxicity caused by cancer therapies / Michael R. Vasko -- 14. Future directions with DNA repair inhibitors / Mark R. Kelley. | |
| 650 | 0 |
_aCancer _xTreatment _xGenetic aspects. |
|
| 650 | 0 | _aDNA repair. | |
| 650 | 1 | 2 | _aDNA Repair. |
| 650 | 1 | 2 |
_aNeoplasms _xdrug therapy. |
| 650 | 2 | 2 |
_aNeoplasms _xgenetics. |
| 700 | 1 |
_aKelley, Mark Richard, _d1957- |
|
| 906 |
_a7 _bcbc _ccopycat _d2 _encip _f20 _gy-gencatlg |
||
| 942 |
_2ddc _cBOOKS |
||
| 999 |
_c15245 _d15245 |
||